Mesenchymal stromal cells for treatment of the acute respiratory distress syndrome: The beginning of the story

In spite of decades of research, the acute respiratory distress syndrome (ARDS) continues to have an unacceptably high mortality and morbidity. Mesenchymal stromal cells (MSCs) present a promising candidate for the treatment of this condition and have demonstrated benefit in preclinical models. MSCs...

Full description

Saved in:
Bibliographic Details
Published in:J Intensive Care Soc
Main Authors: Morrison, T, McAuley, DF, Krasnodembskaya, A
Format: Artigo
Language:Inglês
Published: SAGE Publications 2015
Subjects:
Special Articles
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC5606462/
https://ncbi.nlm.nih.gov/pubmed/28979439
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1751143715586420
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items